Interferon therapy of non-Hodgkin's lymp
β
Kenneth A. Foon; Mark S. Roth; Paul A. Bunn Jr
π
Article
π
1987
π
John Wiley and Sons
π
English
β 459 KB
π 2 views
In 1981, the National Cancer Institute undertook Phase I1 trials of interferon alfa-2a in patients with non-Hodgkin's lymphoma (including cutaneous T-cell lymphoma [CTCL]) and chronic lymphocytic leukemia (CLL). A dose of 50 X lo6 U/m2, three times per week, was used initially, then adjusted downwar